Sequential up-regulation of the c-fos, c-jun and bax genes in the cortex, striatum and cerebellum induced by a single injection of a low dose of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in C57BL/6 mice

Neurosci Lett. 2001 Nov 13;314(1-2):49-52. doi: 10.1016/s0304-3940(01)02281-9.

Abstract

We investigated whether single injection of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) (20 mg/kg) will alter the expression of pro-apoptotic genes, namely, the c-fos, c-jun, and bax, in the striatum, cortex, and cerebellum of adult male C57BL/6 mice using reverse transcription-polymerase chain reaction assay. Injection of MPTP induced a transient decrease in the content of tyrosine hydroxylase estimated by the immunoreactivity in the striatum, which completely recovered 14 day after injection. A rapid but transient up-regulation of c-fos and c-jun genes occurred an hour after MPTP-injection, and a delayed but persistent up-regulation of bax gene expression occurred 3 day after injection. The up-regulation of these genes was present in all the examined brain regions. This result suggests that MPTP, at a low dose causing transient degeneration in the striatum, is capable of triggering two genetic pathways related to the generation of apoptosis in both dopaminergic and non-dopaminergic systems in the mouse brain.

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / pharmacology
  • Animals
  • Apoptosis / drug effects*
  • Apoptosis / physiology
  • Brain / drug effects*
  • Brain / metabolism
  • Brain / physiopathology
  • Cerebellum / drug effects
  • Cerebellum / metabolism
  • Cerebellum / physiopathology
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism
  • Cerebral Cortex / physiopathology
  • Dopamine / metabolism
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / physiology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Neostriatum / drug effects
  • Neostriatum / metabolism
  • Neostriatum / physiopathology
  • Parkinsonian Disorders / genetics*
  • Parkinsonian Disorders / metabolism
  • Parkinsonian Disorders / physiopathology
  • Proto-Oncogene Proteins / drug effects*
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins c-bcl-2*
  • Proto-Oncogene Proteins c-fos / drug effects*
  • Proto-Oncogene Proteins c-fos / genetics
  • Proto-Oncogene Proteins c-jun / drug effects*
  • Proto-Oncogene Proteins c-jun / genetics
  • RNA, Messenger / drug effects
  • RNA, Messenger / metabolism
  • Tyrosine 3-Monooxygenase / metabolism
  • Up-Regulation / drug effects*
  • Up-Regulation / genetics
  • bcl-2-Associated X Protein

Substances

  • Bax protein, mouse
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • Proto-Oncogene Proteins c-fos
  • Proto-Oncogene Proteins c-jun
  • RNA, Messenger
  • bcl-2-Associated X Protein
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Tyrosine 3-Monooxygenase
  • Dopamine